RT Journal Article
SR Electronic
T1 Lower germline mutation rates in young adults predict longer lives and longer reproductive lifespans
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 19004184
DO 10.1101/19004184
A1 Cawthon, Richard M.
A1 Meeks, Huong D.
A1 Sasani, Thomas A.
A1 Smith, Ken R.
A1 Kerber, Richard A.
A1 O’Brien, Elizabeth
A1 Quinlan, Aaron R.
A1 Jorde, Lynn B.
YR 2019
UL http://medrxiv.org/content/early/2019/08/13/19004184.abstract
AB BACKGROUND Genome sequencing of large three-generation families allows identification of de novo mutations (DNMs) in the middle-generation and their attribution to the specific grandparental germlines in which they arose. We hypothesized that germline DNM accumulation during aging may limit the duration of childbearing in women, and if accompanied by mutation accumulation in somatic tissues, reflect aging rates generally in both sexes.Here we test whether germ cell DNMs present in the grandparent generation when they were young adults predict two clinically important outcomes in those same individuals: survival in both sexes, and age-related fertility decline in women.METHODS Germline DNM counts were determined in 122 grandparents from 33 three-generation Utah families and converted to DNM rates by normalizing each subject’s DNM counts to the callable fraction of their genome. Age at death, cause of death, cancer incidence, and reproductive histories were provided by the Utah Population Database and the Utah Cancer Registry. Fertility analyses were restricted to the 53 grandmothers whose age at last birth (ALB) was at least 30 years, the approximate age when the decline in female fertility ending with menopause begins.RESULTS After adjusting for birth year, sex and parental age effects in Cox proportional hazard regression models, a one standard deviation increase in DNM rates was significantly associated with higher all-cause mortality in both sexes combined (hazard ratio [HR], 1.97; 95% confidence interval [CI], 1.12-3.46; p=0.019). Women in the top 75% of DNM rates had higher all-cause mortality than women in the bottom 25% (HR, 2.14; 95% CI, 1.03-4.46; p=0.043); and men in the top 25% of DNM rates had higher all-cause mortality than men in the bottom 25% (HR, 4.37; 95% CI, 1.54-12.44; p=0.006). Among women with ALB ≥ 30 years, those in the top 50% of DNM rates had significantly fewer live births than those in the bottom 25% (p=0.026), and higher DNM rates were significantly associated (p=0.036) with a younger ALB (< 25th percentile, 34.8 years).CONCLUSIONS Germline mutation accumulation rates in healthy young adults may provide a measure of both reproductive and systemic aging. The data further suggest that inter-individual differences in mutation accumulation rates are established around puberty, just when DNA repair genes’ expression levels are known to begin their lifelong decline.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNIH R01AG038797 and R21AG054962 (to R.M.C.); University of Utah Program in Personalized Health (H.D.M.); NIH T32GM007464 (to T.A.S.); NIH R01AG022095 (to K.R.S.); NIH R01HG006693, R01HG009141, and R01GM124355 (to A.R.Q.); NIH GM118335 and GM059290 (to L.B.J.); NIH P30CA2014 (to the Utah Population Database, a.k.a. the UPDB); National Center for Research Resources Public Health Services grant M01RR00064 (to the Huntsman General Clinical Research Center at the University of Utah); and gifts from the W.M. Keck Foundation and the George S. and Delores Doré Eccles Foundation that supported the Utah Genetic Reference Project (UGRP). Sequencing of the CEPH samples was funded by the Utah Genome Project, the George S. and Dolores Doré Eccles Foundation, and the H.A. and Edna Benning Foundation. We thank the Pedigree and Population Resource of the Huntsman Cancer Institute, University of Utah (funded in part by the Huntsman Cancer Foundation) for its role in the ongoing record collection, maintenance and support of the UPDB; and additional support for the UPDB from the University of Utah, and the University of Utah’s Program in Personalized Health and Center for Clinical and Translational Science.Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.Not ApplicableMost of the data analyzed in this manuscript are provided either within the manuscript itself, or in the manuscript posted by Sasani et al. on bioRxiv at https://www.biorxiv.org/content/10.1101/552117v2 and its accompanying links; additional data may be accessed by contacting the corresponding author (Dr. Cawthon). https://www.biorxiv.org/content/10.1101/552117v2